Piotr Wnuk, Author at - Page 6 of 14

The US regulator has approved a drug to treat low potassium as the first generic with the Competitive

FDA approves generic under new strategy to boost competition

https://pharmaphorum.com/news/fda-approved-hypokalymia-generic-cgt/

Digital/ Healthcare/ News/ News/ News/ Patients/ US

US start-up launches bilingual healthcare app

Piotr Wnuk digital health, digital health innovation, digital innovation, HoyDoc, HoyHealth 0 Comment

HoyHealth, an innovative health-tech start-up has launched HoyDoc, smartphone application that connects patients to medical providers through a

US start-up launches bilingual healthcare app

https://pharmaphorum.com/news/us-start-up-launches-bilingual-healthcare-app/

News/ Novo Nordisk

Novo Nordisk hints at US price cuts after Q2 sales fall

Piotr Wnuk Donald Trump, Novo Nordisk, Ozempic, Victoza, Xultrophy 0 Comment

Danish pharma Novo Nordisk posted second-quarter operating profit in line with forecasts but hinted about the possibility of

Novo Nordisk hints at US price cuts after Q2 sales fall

https://pharmaphorum.com/news/novo-nordisk-price-reductions/

blockchain technology in pharma and healthcare

Digital/ Views & Analysis/ Views and analysis

Why AI and blockchain are the solutions to developing orphan drug

Piotr Wnuk AI, Blockchain, Blockchain for Pharma, Innoplexus, orphan drugs 0 Comment

We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing

Why AI and blockchain are the solutions to developing orphan drug

https://pharmaphorum.com/views-analysis-digital/blockchain-solution-developing-orphan-drug/

Digital/ News/ News/ Top stories

Millions of health records exposed to public in Mexico

Piotr Wnuk cyber attack, cyber security, digital health 0 Comment

A German cyber security enthusiast says he discovered an unprotected online healthcare database and gained access to 2.3

Millions of health records exposed to public in Mexico

https://pharmaphorum.com/news/health-records-publically-exposed/

News/ News/ R&D

Antares to develop injector pen drug with Pfizer

Piotr Wnuk Antares Pharma, Auto-injector, Pfizer 0 Comment

New Jersey based Antares has signed a deal with pharma giant Pfizer to develop an auto injector pen

Antares to develop injector pen drug with Pfizer

https://pharmaphorum.com/news/antares-to-develop-injector-pen-drug-with-pfizer/

Digital/ Market Access/ News/ News/ News

Prudential and Babylon join forces in Asia

Piotr Wnuk Babylon Health, digital health, digital health innovation, Prudential 0 Comment

Global insurance giant Prudential signed an exclusive agreement to use Babylon Health’s artificial intelligence (AI) based healthcare application

Prudential and Babylon join forces in Asia

https://pharmaphorum.com/news/prudential-babylon-join-forces-asia/

News/ News/ R&D/ UK & Europe

Boehringer joins UK academics in battle against cystic fibrosis

Piotr Wnuk Boehringer Ingelheim, cystic fibrosis, Cystic Fibrosis Trust, gene therapy 0 Comment

Boehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium announced a global collaboration to develop a

Boehringer joins UK academics in battle against cystic fibrosis

https://pharmaphorum.com/news/boehringer-battles-against-cystic-fibrosis/

AstraZeneca/ Merck Inc/ News/ News/ News/ Oncology/ R&D/ Rare diseases/ Top stories/ UK & Europe

Neurofibromatosis treatment granted orphan status by EMA

Piotr Wnuk ASCO 2018, AstraZeneca, ema, genetic, Merck & Co, Neurofibromatosis, NF1, Oncology, Selumetinib 0 Comment

AstraZeneca and Merck & Co. announced the European Medicines Agency (EMA) has granted orphan designation to their codeveloped

Neurofibromatosis treatment granted orphan status by EMA

https://pharmaphorum.com/news/nf1-treatment-granted-orphan-status-ema/

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

FDA approves generic under new strategy to boost competition

US start-up launches bilingual healthcare app

Novo Nordisk hints at US price cuts after Q2 sales fall

Why AI and blockchain are the solutions to developing orphan drug

Millions of health records exposed to public in Mexico

Antares to develop injector pen drug with Pfizer

Prudential and Babylon join forces in Asia

Boehringer joins UK academics in battle against cystic fibrosis

Neurofibromatosis treatment granted orphan status by EMA

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

Login